BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Presland RB. Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery. World J Transplant 2016; 6(4): 608-619 [PMID: 28058210 DOI: 10.5500/wjt.v6.i4.608]
URL: https://www.wjgnet.com/2220-3230/full/v6/i4/608.htm
Number Citing Articles
1
Zhi-zhi Qin, Jun Ruan, Meng-ran Lee, Kang Sun, Ping Chen, Yan Chen, Mei Hong, Ling-hui Xia, Jun Fang, Hao Tang. Mangiferin Promotes Bregs Level, Activates Nrf2 Antioxidant Signaling, and Inhibits Proinflammatory Cytokine Expression in Murine Splenic Mononuclear Cells In VitroCurrent Medical Science 2021; 41(3): 454 doi: 10.1007/s11596-021-2371-9
2
Mauricio Sarmiento Maldonado, Pablo Ramírez Villanueva, Pablo Bertín Cortes-Monroy, Veronica Jara Arias, Katherine Soto Donoso, Pablo Uribe Gonzalez, Mauricio Ocqueteau Tachini, Jose Antonio Perez-Simón. Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresisExperimental Hematology & Oncology 2017; 6(1) doi: 10.1186/s40164-017-0092-3
3
Daniela Roca, Jessica Mun, Bayasgalan Surenkhuu, Murugesan Vanathi, Sandeep Jain. Dry Eye Disease2023; : 107 doi: 10.1016/B978-0-323-82753-9.00015-1
4
Philipp Eberwein, Sonja Krösser, Philipp Steven. Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional StudyOphthalmic Research 2020; 63(1): 50 doi: 10.1159/000499158
5
Zunirah Ahmed, John M. Vierling. Liver Immunology2020; : 551 doi: 10.1007/978-3-030-51709-0_34
6
Asma El‐Howati, Martin H. Thornhill, Helen E. Colley, Craig Murdoch. Immune mechanisms in oral lichen planusOral Diseases 2023; 29(4): 1400 doi: 10.1111/odi.14142
7
Nathaniel Edward Bennett Saidu, Chiara Bonini, Anne Dickinson, Magdalena Grce, Marit Inngjerdingen, Ulrike Koehl, Antoine Toubert, Robert Zeiser, Sara Galimberti. New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future DirectionsFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.578314
8
Sridevi Nair, Murugesan Vanathi, Ritika Mukhija, Radhika Tandon, Sandeep Jain, Yoko Ogawa. Update on ocular graft-versus-host diseaseIndian Journal of Ophthalmology 2021; 69(5): 1038 doi: 10.4103/ijo.IJO_2016_20
9
Deepika Raman, Charlotte Chêne, Carole Nicco, Mohamed Jeljeli, Jie Qing Eu, Marie-Véronique Clément, Frédéric Batteux, Shazib Pervaiz. Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHDBiology 2023; 12(5): 647 doi: 10.3390/biology12050647
10
Maria Iacobescu, Cristina Pop, Alina Uifălean, Cristina Mogoşan, Diana Cenariu, Mihnea Zdrenghea, Alina Tănase, Jon Thor Bergthorsson, Victor Greiff, Mihai Cenariu, Cristina Adela Iuga, Ciprian Tomuleasa, Dan Tătaru. Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplantsFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1327035
11
Radhika Gangaraju, Yanjun Chen, Lindsey Hageman, Jessica Wu, Liton Francisco, Michelle Kung, Daniel J. Weisdorf, Stephen J. Forman, Mukta Arora, Saro H. Armenian, Smita Bhatia. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk modelBlood Advances 2021; 5(20): 4102 doi: 10.1182/bloodadvances.2021004341
12
Christiane Faust, Tina Dietrich-Ntoukas, Philipp Steven. Zweite Umfrage zur Versorgungsstruktur der okulären Graft-versus-Host Disease in DeutschlandKlinische Monatsblätter für Augenheilkunde 2020; 237(11): 1353 doi: 10.1055/a-0854-3984
13
Shin Mukai. Purinergic SystemBiochemistry 2022; 36 doi: 10.5772/intechopen.104450
14
Frida Schain, Nurgul Batyrbekova, Johan Liwing, Simona Baculea, Thomas Webb, Mats Remberger, Jonas Mattsson. Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host diseaseThe European Journal of Health Economics 2021; 22(1): 169 doi: 10.1007/s10198-020-01249-x
15
Teresa Lopes Ramos, Estefanía García-Guerrero, Teresa Caballero-Velázquez, Alfonso Rodríguez-Gil, Rocío Caracuel-García, Melanie Nufer, María José Robles-Frías, María Victoria Barbado, José A. Pérez-Simón. Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host diseaseBone Marrow Transplantation 2021; 56(12): 3049 doi: 10.1038/s41409-021-01452-1
16
Karin Melanie Cabanillas Stanchi, Manon Queudeville, Carmen Malaval, Judith Feucht, Patrick Schlegel, Markus Dobratz, Christian Seitz, Ingo Müller, Peter Lang, Rupert Handgretinger, Michaela Döring. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patientsJournal of Cancer Research and Clinical Oncology 2019; 145(11): 2779 doi: 10.1007/s00432-019-03008-9
17
Irina Kostareva, Kirill Kirgizov, Elena Machneva, Nadezhda Ustyuzhanina, Nikolay Nifantiev, Yulia Skvortsova, Irina Shubina, Vera Reshetnikova, Timur Valiev, Svetlana Varfolomeeva, Mikhail Kiselevskiy. Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHDPharmaceuticals 2022; 15(9): 1100 doi: 10.3390/ph15091100
18
M. Newmarch, E. Kostantin, G. J. Tsongalis, M. Guimond, J. Roy, V. De Guire, I. Ahmad. MicroRNAs in graft-versus-host disease: a review of the latest dataBone Marrow Transplantation 2020; 55(6): 1014 doi: 10.1038/s41409-019-0764-1
19
Dominique Rongvaux-Gaïda, Maëva Dupuis, Joël Poupon, Nouzha Djebrani-Oussedik, Catherine Lemonnier, François Rieger. High Response Rate and Corticosteroid Sparing with Arsenic Trioxide-Based First-Line Therapy in Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy 2022; 28(10): 679.e1 doi: 10.1016/j.jtct.2022.07.004
20
Zun Pwint Oo, Andrey Bychkov, Yoshiaki Zaizen, Mari Yamasue, Jun-ichi Kadota, Junya Fukuoka. Combination of pleuroparenchymal fibroelastosis with non-specific interstitial pneumonia and bronchiolitis obliterans as a complication of hematopoietic stem cell transplantation — Clues to a potential mechanismRespiratory Medicine Case Reports 2019; 26: 244 doi: 10.1016/j.rmcr.2019.02.001
21
Georgine E. de Greef, Eric Braakman, Bronno van der Holt, Jeroen J.W.M. Janssen, Eefke Petersen, Vladimir Vucinic, Nicole Thuss, Meriam Grootes, Jan J. Cornelissen. The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 studyTransfusion 2019; 59(1): 316 doi: 10.1111/trf.15037
22
R. Stranzenbach, S. Theurich, M. Schlaak. Stellenwert der Stammzelltransplantation in der Therapie kutaner T‑Zell-LymphomeDer Hautarzt 2017; 68(9): 716 doi: 10.1007/s00105-017-4023-3
23
Richard B. Presland. Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applicationsExpert Review of Proteomics 2017; 14(11): 997 doi: 10.1080/14789450.2017.1388166
24
Samreen N. Shaikh, Emily F. Willis, Max Dierich, Yi Xu, Samuel J. S. Stuart, Glenda C. Gobe, Abate A. Bashaw, Oliver Rawashdeh, Seung Jae Kim, Jana Vukovic. CSF-1R inhibitor PLX3397 attenuates peripheral and brain chronic GVHD and improves functional outcomes in miceJournal of Neuroinflammation 2023; 20(1) doi: 10.1186/s12974-023-02984-7
25
Mengmeng Zhang, Yongxia Wu, David Bastian, Supinya Iamsawat, Jinsam Chang, Anusara Daenthanasanmak, Hung D. Nguyen, Steven Schutt, Min Dai, Fangping Chen, Woong-Kyung Suh, Xue-Zhong Yu. Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T CellsFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01461
26
Tiffany N Caza, Kenar D Jhaveri. Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanismsClinical Kidney Journal 2023; 16(6): 896 doi: 10.1093/ckj/sfad023
27
Michelle A. Borg, Reem A. Shalabi, Richard Childs, Brian C. Wells. Alopecia Universalis and Chronic Graft-vs-Host Disease Treated With RuxolitinibJAMA Dermatology 2018; 154(11): 1357 doi: 10.1001/jamadermatol.2018.2927